glp-1 obesity drug news weight loss drugs leave users low on key nutrients, study finds GLP-1 weight loss drugs to

Enrolled participants had a mean baseline A1C of 8.1% in both treatment groups

Kahal H, Kilpatrick E, Rigby A, Coady A, Atkin S

They are often marketed under the brand names Victoza or Saxenda, Ozempic or Wegovy and Mounjaro or Zepbound, respectively

More was spent by Novo Nordisk on shareholder enrichment in the form of stock buybacks and dividends than on R&D, a hallmark of the financialized pharmaceutical business model

And depending on your situation, certain supplements might be helpful toojust run it by a healthcare professional, like a Midi clinician, first

Methods The Lahey Hospital and Medical Center Institutional Review Board deemed this cohort study exempt from ethics review and the informed consent requirement since the analysis used aggregate, anonymized data from a research network database